Evaluation and Referral of Dyspareunia in Young Women

Infectious Etiologies

Cervicitis caused by sexually transmitted infections is the primary consideration in sexually active women presenting with dyspareunia and burning sensations. CDC recommends early evaluation for this condition. 1
Women younger than 25 years have the highest prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections, which frequently manifest as dyspareunia and burning. CDC surveillance data support this age‑related risk. 1
Genital herpes should be strongly considered because it produces burning pain and characteristic vesicular or ulcerative genital lesions. European CDC advises targeted antiviral therapy when herpes is identified. 4
Gynecologists are equipped to obtain cervical nucleic acid amplification tests (NAATs) for chlamydia and gonorrhea, perform a comprehensive vaginal examination for discharge, and visually inspect for herpetic lesions. CDC guidelines outline these diagnostic steps. [1][4]

Lichen sclerosus commonly presents with dyspareunia and a “burning and tearing” sensation in young women. The British Association of Dermatologists notes this as a typical clinical picture. 5
The disease causes vulvar fissuring that leads to dysuria and painful intercourse. British Association of Dermatologists recommends recognizing fissures as a hallmark of lichen sclerosus. 5
Diagnosis requires visual inspection of the vulvar tissue and may include a biopsy; both procedures are routinely performed by gynecologists. British Association of Dermatologists guidelines endorse biopsy when the diagnosis is uncertain. 5
The descriptive “burning and tearing” terminology strongly suggests mucosal trauma or inflammatory vulvar disease rather than purely infectious causes. British Association of Dermatologists emphasizes this clinical clue. 6

IC/PBS frequently presents with dyspareunia in young women and should be included in the differential diagnosis. The American Urological Association highlights dyspareunia as a common symptom of IC/PBS. 7
Typical IC/PBS symptomatology also includes urinary urgency, frequency, and nocturia, which extend beyond isolated sexual pain. American Urological Association recommends evaluating these additional urinary signs. 7

Referral to urology is appropriate when urinary symptoms (frequency, urgency, nocturia, incomplete emptying) predominate over sexual symptoms. American Urological Association advises this referral pathway. 7
Persistent dyspareunia after appropriate treatment of infectious or gynecologic causes warrants urologic evaluation for possible IC/PBS. American Urological Association supports this step. 7
Suspected urethral involvement or meatal stenosis—though rare in females—should prompt urologic assessment. This recommendation is derived from dermatologic observations of urethral pathology. 5

Do not empirically prescribe antibiotics without a confirmed infectious diagnosis, as this can lead to recurrent symptoms and unnecessary antimicrobial exposure. CDC cautions against indiscriminate antibiotic use.
Do not assume a urinary tract infection (UTI) based solely on dysuria; in young sexually active women, vaginal discharge or cervicitis are more probable etiologies. CDC emphasizes accurate differential diagnosis. [1][2]
Do not delay STI testing; untreated cervicitis can progress to pelvic inflammatory disease (PID) with serious reproductive sequelae. CDC recommends prompt testing and treatment. [1][8]9
Do not overlook genital herpes, which requires specific antiviral therapy to prevent recurrences. European CDC stresses targeted antiviral management. 4

Perform a pelvic examination with thorough visual inspection for lesions, fissures, or vulvar changes. European CDC and British Association of Dermatologists outline this as the first step. [4][5]6
Obtain cervical NAAT testing for Chlamydia and Gonorrhea. CDC testing protocols specify NAAT as the preferred method. [1][2]
Conduct a wet mount and measure vaginal pH to evaluate for bacterial vaginosis or trichomoniasis. CDC laboratory guidelines recommend these tests. [1][2]
Order a urinalysis to document pyuria if present; a negative urinalysis does not exclude cervicitis. CDC advises interpreting UA results in the clinical context. 2
Perform HSV testing (PCR or culture) when vesicular or ulcerative lesions are observed. European CDC recommends targeted HSV diagnostics. 4
Consider vulvar biopsy when lichen sclerosus is suspected based on clinical appearance. British Association of Dermatologists supports biopsy for definitive diagnosis. [5][6]

If the gynecologic assessment is unrevealing and urinary symptoms such as frequency, urgency, or suprapubic pain are prominent, refer the patient to urology for evaluation of IC/PBS. American Urological Association outlines this referral trigger. 7